SNAP-8 at a glance
A fast read for beginners, with evidence strength, route context, safety depth, and community activity surfaced before the deeper sections.
SNAP-8 (Acetyl Octapeptide-3) is a synthetic 8-amino acid peptide derived from the N-terminal sequence of SNAP-25 (synaptosomal-associated protein 25), a key component of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor) protein complex that mediates neurotransmitter vesicle fusion at the neuromuscular junction. By competitively interfering with SNARE complex assembly, SNAP-8 reduces acetylcholine release at the neuromuscular junction, leading to decreased muscle fiber contraction intensity.
The practical application is cosmetic: repetitive facial muscle contractions (squinting, frowning, smiling) generate mechanical stress in the overlying dermis, eventually forming permanent expression lines. SNAP-8 is designed to reduce the frequency and intensity of these micro-contractions in a manner analogous to botulinum toxin (Botox) but without the toxin's irreversible mechanism. Rather than blocking SNARE complex function entirely, SNAP-8 competes with SNAP-25 to partially and reversibly modulate it.
In vitro studies using validated wrinkle models and ex vivo skin samples have shown that SNAP-8 reduces the depth of expression lines by approximately 30 - 35% after topical application, with effects attributed to both reduced muscle contraction and direct effects on extracellular matrix proteins. Human clinical studies conducted by cosmetic ingredient suppliers show improvements in periocular and perioral wrinkle depth with regular topical use.
The evidence base relies heavily on industry-sponsored studies with small sample sizes and short follow-up periods. SNAP-8 is marketed in cosmetic formulations at concentrations of 3 - 10%, typically in eye creams and anti-wrinkle serums. No rigorous Phase 2/3 clinical trials meeting pharmaceutical standards have been published.
Key Benefits
Saves this peptide to your Watchlist and helps you find new research, news, and questions later.